Thermo Fisher Scientific Inc (TMO): Price and Financial Metrics


Thermo Fisher Scientific Inc (TMO)

Today's Latest Price: $365.89 USD

6.12 (1.70%)

Updated Jul 2 7:00pm

Add TMO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

TMO Stock Summary

  • With a market capitalization of $143,106,583,023, Thermo Fisher Scientific Inc has a greater market value than 98.97% of US stocks.
  • TMO's went public 32.85 years ago, making it older than 91.61% of listed US stocks we're tracking.
  • In terms of volatility of its share price, TMO is more volatile than only 2.8% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Thermo Fisher Scientific Inc are NVO, NKE, TMUS, DHR, and ABT.
  • TMO's SEC filings can be seen here. And to visit Thermo Fisher Scientific Inc's official web site, go to www.thermofisher.com.
TMO Daily Price Range
TMO 52-Week Price Range

TMO Stock Price Chart Technical Analysis Charts


TMO Price/Volume Stats

Current price $365.89 52-week high $369.82
Prev. close $359.77 52-week low $250.21
Day low $362.00 Volume 1,127,751
Day high $369.82 Avg. volume 1,895,976
50-day MA $343.24 Dividend yield 0.24%
200-day MA $317.04 Market Cap 144.51B

Thermo Fisher Scientific Inc (TMO) Company Bio


Thermo Fisher Scientific provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. The company was founded in 1956 and is based in Waltham, Massachusetts.

TMO Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$365.89$149.3-57%

Below please find a table outlining a discounted cash flow forecast for TMO, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Thermo Fisher Scientific Inc ranked in the 28th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 57.17%. As for the metrics that stood out in our discounted cash flow analysis of Thermo Fisher Scientific Inc, consider:

  • Interest coverage, a measure of earnings relative to interest payments, is 6.09; that's higher than 57.7% of US stocks in the Healthcare sector that have positive free cash flow.
  • 88% of the company's capital comes from equity, which is greater than 74.78% of stocks in our cash flow based forecasting set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-58%
1%-58%
2%-57%
3%-57%
4%-57%
5%-56%

BHC, CMD, ENTA, WAT, and ABT can be thought of as valuation peers to TMO, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


TMO Latest News Stream


Event/TimeNews Detail
Loading, please wait...

TMO Latest Social Stream


Loading social stream, please wait...

View Full TMO Social Stream

Latest TMO News From Around the Web

Below are the latest news stories about Thermo Fisher Scientific Inc that investors may wish to consider to help them evaluate TMO as an investment opportunity.

Major Qiagen shareholder demands higher bid from Thermo Fisher - source

The coronavirus pandemic has boosted Qiagen's prospects and a takeover by Thermo Fisher no longer makes sense unless the offer is increased substantially, one of the German genetic test maker's top ten shareholders told Reuters on Friday. Thermo Fisher agreed in early March to buy Qiagen for $11.5 billion as the U.S.-based company looks to bolster its health diagnostic business. Qiagen has seen high demand for products related to coronavirus testing and began shipping a rapid diagnostic test for COVID-19 to the United States at the end of March.

Yahoo | July 3, 2020

Were Hedge Funds Right About Piling Into Thermo Fisher Scientific Inc. (TMO)?

We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. We are almost done with the second quarter. Investors decided […]

Yahoo | July 2, 2020

Why Thermo Fisher (TMO) is Poised to Beat Earnings Estimates Again

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Yahoo | July 2, 2020

The Zacks Analyst Blog Highlights: Facebook, Thermo Fisher Scientific, McDonalds, NIKE and QUALCOMM

The Zacks Analyst Blog Highlights: Facebook, Thermo Fisher Scientific, McDonalds, NIKE and QUALCOMM

Yahoo | July 2, 2020

3 AI Healthcare Stocks to Ride Out the Coronavirus Resurgence

Efficient use of data by artificially intelligent applications has put into the spotlight their urgent need in the healthcare domain.

Yahoo | July 2, 2020

Read More 'TMO' Stories Here

TMO Price Returns

1-mo 5.16%
3-mo 29.74%
6-mo 12.69%
1-year 22.02%
3-year 110.00%
5-year 185.39%
YTD 12.79%
2019 45.55%
2018 18.21%
2017 35.03%
2016 -0.12%
2015 13.75%

TMO Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full TMO Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.934 seconds.